A low dose of methimazole is generally considered to be 5 to 10 mg per day, which is the range most commonly used for maintenance therapy once thyroid levels have stabilized. This sits well below the starting doses of 15 to 60 mg per day that are typically prescribed when hyperthyroidism is first diagnosed. Understanding where your dose falls on this spectrum matters because both effectiveness and side effect risk shift meaningfully with dosage.
How Dosing Tiers Break Down
Methimazole dosing follows a pattern: start higher to get thyroid hormones under control, then taper down to the lowest effective amount. The tiers look roughly like this:
- Low dose: 5 to 10 mg per day, used for maintenance or mild hyperthyroidism
- Moderate dose: 15 to 20 mg per day, a common starting point for mild to moderate cases
- High dose: 30 to 60 mg per day, reserved for moderately severe to severe hyperthyroidism
The manufacturer recommends a maintenance range of 5 to 15 mg daily, though many clinicians aim for the lower end of that window, targeting 5 to 10 mg per day once thyroid function normalizes. Some patients on long-term therapy end up stable on as little as 2.5 to 5 mg per day, though this isn’t always enough to maintain remission.
It’s worth noting that what researchers call “low dose” in clinical studies doesn’t always match what your prescriber means. Several studies define 10 to 20 mg per day as a “low daily dosage” when comparing it against older high-dose protocols of 30 mg or more. So if you see “low dose” referenced in medical literature, the actual number may be higher than you’d expect. In everyday clinical practice, though, most endocrinologists use “low dose” to mean 10 mg per day or less.
Why Doses Start High and Come Down
Methimazole works by blocking a key enzyme in the thyroid gland that’s responsible for producing thyroid hormones (T3 and T4). It essentially shuts down the assembly line. But here’s the catch: even after the drug starts working, your thyroid has a stored supply of hormones already made. Those stores need to be used up before your blood levels actually drop, which is why it can take several weeks before you feel different.
Higher starting doses ensure the enzyme is thoroughly blocked while those stores deplete. Once your levels normalize, a much smaller amount of the drug is enough to keep production in check. That’s when your prescriber will begin tapering toward a low maintenance dose. Thyroid function tests are typically rechecked every 3 to 4 weeks during this adjustment phase, and the dose is titrated based on your free T4 and free T3 levels.
How Low Dose Affects Side Effect Risk
One of the main reasons clinicians aim for the lowest effective dose is that the most serious side effect of methimazole, a dangerous drop in white blood cells called agranulocytosis, is dose-dependent. A 2024 study quantified this clearly: the incidence was 0.13% at 10 mg per day, 0.20% at 15 mg, 0.32% at 20 mg, and 0.47% at 30 mg per day. That’s roughly a threefold difference in risk between a low dose and a high dose.
The overall risk remains small at any dose, but the pattern is consistent. Staying at 10 mg or below meaningfully reduces your chances of this complication. Other side effects like skin rash, joint pain, and stomach upset also tend to be less frequent at lower doses, though these are less well quantified in the literature.
Long-Term Low-Dose Therapy
The standard approach for Graves’ disease is to take methimazole for 12 to 18 months, then stop and see whether the disease stays in remission. But not everyone achieves lasting remission, and some people relapse repeatedly. For those patients, long-term low-dose methimazole is an increasingly accepted option. Rather than moving to radioactive iodine or surgery, you simply continue taking a small daily dose indefinitely.
This strategy works best when your thyroid levels stay stable on 5 to 10 mg per day and you tolerate the medication well. The European Thyroid Association guidelines acknowledge this as a reasonable approach for patients who prefer ongoing medication over more permanent treatments. The low side effect profile at these doses makes years-long use practical for many people.
Once Daily vs. Split Doses
At higher doses, methimazole is often split into two or three doses throughout the day (for example, 5 mg three times daily to reach 15 mg). But at low doses, once-daily dosing is both simpler and equally effective. Despite having a relatively short half-life of 4 to 6 hours, methimazole’s effect on the thyroid enzyme it blocks lasts longer than the drug itself stays in your bloodstream. This means a single daily dose of 5 or 10 mg is enough for most people on maintenance therapy.
Methimazole comes in 5 mg and 10 mg tablets, making low-dose regimens straightforward without needing to split pills. If your target dose is 2.5 mg, you would split a 5 mg tablet, but most maintenance regimens use whole tablets.
What Monitoring Looks Like at Low Doses
Even on a stable low dose, you’ll still need periodic blood work. During the initial dose adjustment phase, thyroid function is checked every 3 to 4 weeks. Once your levels have been stable for several months, testing intervals typically stretch to every 3 to 6 months. Your prescriber is watching free T4, free T3, and TSH to make sure you’re not being over-treated (which would push you into hypothyroidism) or under-treated (which means the hyperthyroidism is breaking through).
Signs that your low dose may need adjusting include returning symptoms like rapid heart rate, weight loss, or heat intolerance (dose too low), or new symptoms like fatigue, weight gain, and cold sensitivity (dose too high). Small adjustments of 2.5 to 5 mg can make a noticeable difference at these lower ranges, so even minor symptom changes are worth reporting.